A series of 4-aryl-N-(4-pheny-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides were synthesized by condensing 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid with 2-amino-4-aryl-thiazole derivatives. The newly synthesized molecules were characterized by spectral analysis and subjected to antioxidant and DNA damage inhibition studies.
Introduction
Oxadiazines are interesting and promising sixmembered heterocyclic compounds with oxygen and nitrogen atoms. 1,3,4-oxadiazine derivatives exhibit biological activities such as cardiovascular, antibacterial, plant growth regulating, miticidal and nematocidal, acricidal, insecticidal and anticonvulsive activities. 1 In addition, oxadiazine derivatives are also used as drugs for the treatment of anaemia 2 and viral diseases. 3 Thiazoles are important class of natural and synthetic compounds and display a wide range of biological activities such as cardiotonic, 4 sedative, 5 anaesthetic, 6 bactericidal 7 and anti-inflammatory. 8 The main characteristic of an antioxidant is its ability to trap free radicals. Highly reactive free radicals or reactive oxygen species (ROS) are present in biological systems from a wide variety of sources. 9 These free radicals can cause a number of chain reactions and may oxidize nucleic acids, proteins, lipids or DNA and can initiate several diseases. 10 Antioxidants terminate these chain reactions by removing free radical intermediates and inhibit other oxidation reactions, thus inhibiting the oxidative mechanism that leads to degenerative diseases. They do this by oxidizing themselves, so antioxidants are often reducing agents. Antioxidants are widely used as dietary supplements and are being investigated for the prevention of diseases such as cancer, coronary heart disease and even altitude sickness. 11 DNA damage can lead to mutation if replication proceeds without proper repair. Oxidative stress-induced * For correspondence DNA damage by the reactive oxygen species and chemical carcinogens can lead to mutations and is suspected to be a major cause of cancer. 12 In order to protect the genome from deleterious effects of ROS, cells have antioxidants, ROS-eliminating enzymes and efficient DNA repair pathways. Among DNA damage causing cancer development, approximately 80% of the damage is caused by ROS such as hydrogen peroxide (H 2 O 2 ), singlet oxygen ( 1 O 2 ) and hydroxyl radical ( • OH). Therefore, protection of oxidative DNA damage induced by ROS is very important for cancer prevention. 13 Benzoxadiazines derived from embelin (herbs extract) is reported to exhibit antioxidant and free radical scavenging activities.
14 Various oxadiazines linked with other heterocyclic moieties show enhanced biological activities. 15 -17 In addition, oxadiazines bearing thiazole moiety exhibit antifungal activities. 18 In order to achieve promising antioxidants, we have synthesized a new series of 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides (7a-l) by condensing 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid (6a-d) with 2-amino-4-aryl-thiazole derivatives (2a-d) as illustrated in schemes 1 and 2.
Experimental
The melting points were measured with micro melting point apparatus and are uncorrected. All chemicals/reagents used were purchased from Merck Chemicals (India), Fluka Chemicals (India) and IR spectra were recorded in KBr pellets on Shimadzu 8300 spectrometer. The 1 H NMR spectra were recorded on a Bruker supercon 400 MHz spectrophotometer using DMSO-d 6 as solvent and Tetra methyl silane (TMS) as an internal standard. The chemical shifts were expressed in ppm. Mass spectra were obtained on LC-MSD-Trap-XCT-Plus spectrophotometer. Thin layer chromatography (TLC) was performed on pre-coated Silica Gel sheet (HF 254, Sd-fine) and visualization of the spots was done in iodine vapour and UV light. Chromatographic separations were carried out on silica gel (60-120) mesh using petroleum ether: acetone (9:1) as eluent (scheme 3).
General procedure for the synthesis of 2-amino-4-aryl-thiazole 2a-d
2-amino-4-aryl thiazole derivatives were prepared 19 -21 using different substituted phenacyl bromides by refluxing with excess thiourea in presence of conc. HCl for about 20 min. After the completion of reaction, the reaction mixture was cooled to room temperature; the pale yellow solid thus separated was filtered, washed with chloroform, dried and recrystallized from ethanol to obtain 2-amino-4-aryl thiazole derivatives.
Typical procedure for the synthesis of 4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid: (6a)
An oven-dried two-neck round bottom flask was charged with a solution of 4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylate 22 -24 (5a, 2.35 g, 10.00 mmol) in 25 mL of methanol. A volume of 10 mL of 5% NaOH solution was added dropwise to the reaction mixture and allowed to stir at room temperature for 24 h. After completion of reaction (monitored by TLC), methanol was evaporated under reduced pressure and the residue was acidified with dil. HCl. The white solid thus separated was filtered, dried and recrystallized from 20 mL ethanol to obtain 4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid (6a, 1.64 g) 80% yield; IR (KBr cm 
Typical procedure for the synthesis of 4-phenyl-N-(4-phenyl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides (7a)
4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid (6a, 2.30 g, 11.00 mmol) was taken in round bottomed flask and dissolved in 30 mL of CHCl 3 , after 10 min, HOBt (2.00 g, 15.00 mmol) and 1-ethyl-3-(3-dimethylaminopropyl) carbodimide (EDC.HCl) (2.81 g, 15.00 mmol) were added. The reaction mixture was stirred at room temperature for 15 min, then 2-amino-4-phenyl thiazole (2a, 1.76 g, 10.00 mmol) and 1.15 mL (11.00 mmol) of triethylamine were added and stirred at room temperature for about 5-6 h. After completion of reaction (monitored by TLC), the reaction mixture was extracted with CHCl 3 (3 × 20 mL). The combined organic layer was washed with 5% NaHCO 3 solution followed by 5% HCl solution and finally with distilled water and then dried over anhydrous Na 2 SO 4 . The CHCl 3 layer was evaporated under reduced pressure; the crude solid thus obtained was purified by column chromatography using petroleum ether: acetone (8:2) as eluent, which afforded 4-phenyl-N-(4-phenyl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7a, 2.05 g) as pale yellow solid in 55% yield, mp 126-128
• C. IR (KBr cm 
2.3a 4-Phenyl-N-(4-(4-chlorophenyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7b):
Obtained from 6a (2.30 g, 11.00 mmol) and 2b (2.10 g, 10.00 mmol), yield 58% (2.32 g); IR (KBr cm 
2.3b 4-Phenyl-N-(4-(4-hydroxyphenyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7c):
Obtained from 6a (2.30 g, 11.00 mmol) and 2c (1.92 g, 10.00 mmol), yield 56% (2.13 g); IR (KBr cm 
2.3f 4-(4-Chlorophenyl)-N-(4-(p-tolyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7g):
Obtained from 6b (2.62 g, 11.00 mmol) and 2d (1.90 g 10.00 mmol), yield 60% (2.48 g); IR (KBr cm 
2.3g 4-(4-Methoxyphenyl)-N-(4-(4-chlorophenyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7h):
Obtained from 6c (2.68 g, 11.00 mmol) and 2b (2.10 g, 10.00 mmol) yield 59% (2.52 g); IR (KBr cm 
2.3h 4-(4-Methoxyphenyl)-N-(4-(4-hydroxyphenyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7i):
Obtained from 6c (2.68 g, 11.00 mmol) and 2c (1.92 g, 10.00 mmol), yield 59.5% (2. 
2.3i 4-(4-Methoxyphenyl)-N-(4-(p-tolyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7j):
Obtained from 6c (2.68 g, 11.00 mmol) and 2d 
2.3j 4-(4-Nitrophenyl)-N-(4-(4-chlorophenyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7k):
Obtained from 6d (2.72 g, 11.00 mmol) and 2b (2.10 g, 10.00 mmol) yield 57% (2. 
2.3k 4-(4-Nitrophenyl)-N-(4-(p-tolyl)-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamide (7l):
Obtained from 6d (2.72 g 11.00 mmol) and 2d (1.90 g 10.00 mmol), yield 58% (2.45 g); IR (KBr cm 
Biological studies of 4-Aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l

2.4a Antioxidant studies:
2.4b DPPH radical scavenging assay: Antioxidant activity of the synthesized 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l in comparison to standard antioxidant butylated hydroxyl toluene (BHT) on DPPH radical was estimated according to the method of Lai et al. 25 Samples 7a-l (10, 50 and 100 µg/mL) and BHT (0-5 µg/mL) were taken in methanol in 200 µL aliquot and mixed with 100 mM Tris-HCl buffer (800 µL, pH 7.4) and then 1 mL of 500 µM DPPH was added in ethanol (final concentration of 250 µM). The mixture was shaken vigorously and left to settle for 20 min at room temperature in the dark. Absorbance of the resulting solution was measured spectrophotometrically at 517 nm. The capability to scavenge DPPH radical was calculated using eq. (1).
DPPH Scavenging activity (%)
= A control − A sample /A control × 100 (1) 2.4c Measurement of reducing power: The reducing power of synthesized 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l was determined according to the method of Yen and Chen. 26 The samples 7a-l (10, 50 and 100 μg/mL) were mixed with equal volumes of 0.2 M phosphate buffer (pH 6.6) and 1% potassium ferricyanide. The mixture was incubated at 50
• C for 20 min. Then, an equal volume of 10% trichloroacetic acid was added to the mixture and then centrifuged at 5000 rpm for 10 min. The upper layer of solution was mixed with distilled water and 0.1% ferric chloride at a ratio of 1:1:2 and the absorbance were measured at 700 nm. Increased absorbance of the reaction mixture indicated increased reducing power.
2.4d DNA damage inhibition assay: DNA damage inhibition ability of synthesized 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l was performed using lambda phage DNA. 27, 28 Briefly, lambda phage DNA (0.6 μg) was subjected to oxidation using Fenton's reagent (0.3 mM hydrogen peroxide, 0.5 μM ascorbic acid and 0.8 μM ferric chloride) in presence and absence of the sample (0.2 mg) for 2 h at 37
• C. The samples 7a-l were subjected to electrophoresis (Bio-rad Gel electrophoresis unit) on 1% agarose for 2 h at 50 volts DC. Gels were stained with ethidium bromide (0.5 μg/mL) and documented (Bio-rad gel documentation unit).
2.4e Statistical analysis:
All the experiments were carried out in triplicates (n = 3) and the results were expressed as mean ± standard deviation (SD) as shown in table 1. Graphical representation of DPPH radical scavenging activity of the synthesized 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l is as shown in figures 1-3. Pictorial representation of DNA damage inhibition activity is shown in figure 4.
Results and Discussion
Derivatives of 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid 6a-d were obtained from 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylates 5a-d on treating with 5% NaOH solution using methanol as a solvent for about 24 h. The obtained compounds 6a-d were soluble in 5% NaHCO 3 and reprecipitated on acidification, which indicated the formation of 4-phenyl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acid. Structural proof for the compounds 6a-d was confirmed by spectral studies. For instance, in IR spectra, signal at 1725-1736 cm −1 of >C=O is shifted to 1680-1695 cm −1 and a signal appeared at 2733-2745 cm −1 due to -OH group. In 1 H NMR Table 1 . DPPH radical scavenging activity and reducing power of samples 7a-l compared with standard antioxidant BHT. spectra, the absence of quartet in the region δ 4.12-4.31 ppm, (2H for -OCH 2 group) and triplet in the region δ 1.18-1.30 ppm, (3H for -OCH 2 -CH 3 group) and the presence of carboxylic acid peak at δ 11.82-11.85 ppm confirmed the formation of product 6a-d. In 13 C NMR, peak due to -CH 3 at δ 13.7-13.9 ppm and -OCH 2 at δ 60.9-61.4 ppm disappeared and the peak, due to -C=O shifted to δ 168.1-168.2 ppm from δ 158.4-158.6 ppm. All the synthesized 4-aryl-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxylic acids showed (M+H) + peak which was consistent with the assigned structure in the mass spectra.
The obtained compounds 6a-d were condensed with 2-amino-4-aryl-thiazole derivatives 2a-d to give 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l. The obtained samples 7a-l were confirmed by IR, 1 H NMR, 13 C NMR and MS studies. The IR spectra shows the amide -NH Figure 1 . DDPH radical scavenging assay of 7a-l. frequency in the region 3112.4-3120.9 cm −1 and -C=O frequency region 1670.2-1690.5 cm −1 . 1 H NMR spectra shows, the absence of carboxylic acid peak at δ 11.82-11.85 ppm and the appearance of single small peak due to -CONH-protons in the region δ 12.24-12.31 ppm. The peaks of aromatic protons due to substituted thiazole moiety appear at δ 7.4-8.12 ppm, and in all the derivatives, one singlet peak of thiazole -CH-proton appeared at δ 7.65-7.69 ppm. In 13 C NMR, in addition to aromatic carbon peaks at δ 113-154 ppm, a single peak at δ 105.4-105.9 ppm appeared in all the derivatives. All the 4-aryl-N-(4-aryl-thiazol-2-yl)-5,6-dihydro-4H-1,3,4-oxadiazine-2-carboxamides 7a-l showed (M+H) + peak in the mass spectra. The above spectral evidence confirms the formation of products.
Antioxidant activity of samples 7a-l
3.1a DPPH radical scavenging assay: The free radical scavenging ability of samples 7a-l was evaluated by DPPH scavenging model system using eq. (1). All the samples 7a-l showed free radical scavenging ability. The data from table 1 reveals that compounds 7a-l of synthesized derivatives 7a-l exhibit good DPPH free radical scavenging activity compared to standard antioxidant (BHT). These results indicate the potential electron donating ability of the samples. The DDPH radical scavenging assays of 7a-l are shown graphically in figures 1 and 2.
3.1b Reducing ability study of 7a-l: Reducing power of samples 7a-l was also evaluated (table 1) for their ability to reduce ferric chloride and potassium ferricyanide complex. At the initial concentrations (10 μg/mL), no significant differences in the activity were observed. However, as the concentration was increased (50-100 μg/mL), reducing power also increased. Increased absorbance at 700 nm indicated the reducing ability of the synthesized compounds. The enhanced reducing power of 7h and 7c may be due to the presence of electron donating groups at para position of the phenyl ring. Graphical representation of reducing power is shown in figure 3. 3.1c DNA damage inhibition studies: DNA damage inhibition ability of samples 7a-l was evaluated on lambda phage DNA oxidation. The hydroxyl radical generated by Fenton's reagent caused DNA fragmentation with increase in its electrophoresis mobility and thereby the fragments had run out of the gel (lane 2). Treatment of samples 7a-l prior to oxidation minimized the extent of DNA damage. As evidenced by gel documentation analysis, compared to negative DNA (figure 4), out of all the samples compounds having electron donating groups at para-position of the aryl group, 7e, 7h, 7c and 7f, showed better DNA damage inhibition. Electrophoretic mobility of DNA is shown in figure 4.
Conclusions
We have synthesized a new series of compounds 7a-l and evaluated them for their DNA damage inhibition and antioxidant activities. Compounds 7e, 7h, 7c and 7f having electron donating groups at para position of aryl moiety demonstrated potent antioxidant activity and DNA damage inhibition compared to the standard. These compounds might be blocking the process of oxidation by neutralizing free radicals via interaction of the lone pair of electrons (on -Cl, -OCH 3 and -OH) with DPPH radical.
